1. Revance Therapeutics Inc
  2. Revance Therapeutics Inc Ownership

Historical shareholding details of Rice Hall James & Associates, LLC holdings in Revance Therapeutics Inc (RVNC)

Monthly changes of Rice Hall James & Associates, LLC shareholding in Revance Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Rice Hall James & Associates, Llc 51,768 0.05%
Dec 31, 2024 Rice Hall James & Associates, Llc 678,541 0.65%
Dec 31, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Nov 30, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Oct 31, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Sep 30, 2024 Rice Hall James & Associates, Llc 730,190 0.70%
Sep 30, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Aug 31, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Jul 31, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Jun 30, 2024 Rice Hall James & Associates, Llc 712,072 0.68%
Jun 30, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
May 31, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Apr 30, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Mar 31, 2024 Rice Hall James & Associates, Llc 746,139 0.71%
Mar 31, 2024 Rice Hall James & Associates, Llc 51,768 0.05%
Feb 29, 2024 Rice Hall James & Associates, Llc 51,768 0.06%
Jan 31, 2024 Rice Hall James & Associates, Llc 51,768 0.06%
Dec 31, 2023 Rice Hall James & Associates, Llc 758,048 0.73%
Dec 31, 2023 Rice Hall James & Associates, Llc 51,768 0.06%
Nov 30, 2023 Rice Hall James & Associates, Llc 51,768 0.06%
Oct 31, 2023 Rice Hall James & Associates, Llc 44,844 0.05%
Sep 30, 2023 Rice Hall James & Associates, Llc 683,937 0.78%
Sep 30, 2023 Rice Hall James & Associates, Llc 35,435 0.04%
Aug 31, 2023 Rice Hall James & Associates, Llc 35,435 0.04%
Jul 31, 2023 Rice Hall James & Associates, Llc 35,469 0.04%
Jun 30, 2023 Rice Hall James & Associates, Llc 552,495 0.63%
Jun 30, 2023 Rice Hall James & Associates, Llc 36,145 0.04%
May 31, 2023 Rice Hall James & Associates, Llc 43,124 0.05%
Mar 31, 2023 Rice Hall James & Associates, Llc 809,176 0.96%

View all ownership details of Revance Therapeutics Inc